For how we live.
A surveillance analysis of WHO data from January 2024 to February 2026 tracks the clade Ib emergency from declaration to its end, and finds reported spread continued after the emergency was formally lifted.
A national surveillance study found 415 children under 15 among Sierra Leone's 2024–2025 clade IIb mpox cases — three died, three-quarters needed hospital care, and household contact was the top documented exposure.
A review of the Africa CDC and WHO response reports 49,803 confirmed cases and 240 deaths across 28 countries, US$977 million mobilised, and just 32% of 3.1 million delivered vaccine doses administered.
An observational study across four DR Congo outbreak sites estimates that a third of positive mpox PCR results reflect environmental viral DNA, not infection — and that a stricter cutoff fixes most of it.
Gavi is funding a standing mpox vaccine stockpile, coordinated by the same group that manages emergency supplies for cholera, yellow fever and Ebola, to avoid repeating the 2022 access gap.
In South Kivu, ophthalmologists examined 310 patients with confirmed clade Ib mpox at four time points. Periorbital lesions and severe acute malnutrition tripled the risk of ocular involvement.
WHO's latest mpox report shows global case counts holding steady, but flags a Sindh province cluster where nearly all deaths were in babies under six months old.
WHO reports two cases of a monkeypox virus carrying genetic material from both clade Ib and clade IIb. The finding that matters for surveillance is that clade differentiation PCR missed it both times.
A prospective cohort of 88 index cases and 432 household contacts found a secondary attack rate of 6.15%, three times higher in under-15s. The estimated R0 inside households was 0.30.
A Federal Register notice on 9 June listed eleven vaccine topics and ten scheduled votes over three days. An amended notice on 24 June listed seven topics, three votes and two days.